N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide

C15H16ClN3O3S2 — CID 157050337

IUPACN-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide
SMILESCC(=O)[C@@H]1CSC(c2csc(CNC(=O)CC(=O)C3(Cl)CC3)n2)=N1
InChIInChI=1S/C15H16ClN3O3S2/c1-8(20)9-6-24-14(19-9)10-7-23-13(18-10)5-17-12(22)4-11(21)15(16)2-3-15/h7,9H,2-6H2,1H3,(H,17,22)/t9-/m0/s1
InChIKeyHPHSYNXCOKIALU-VIFPVBQESA-N
MW385.90 g/mol
LogP1.94
Rot. Bonds7

About N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide

N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide (PubChem CID 157050337) has the molecular formula C15H16ClN3O3S2 and a molecular weight of 385.90 g/mol. Its IUPAC name is N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide.

Molecular Properties

Compound NameN-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide
PubChem CID157050337
Molecular FormulaC15H16ClN3O3S2
Molecular Weight385.90 g/mol
Exact Mass385.03
IUPAC NameN-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide
SMILESCC(=O)[C@@H]1CSC(c2csc(CNC(=O)CC(=O)C3(Cl)CC3)n2)=N1
InChIInChI=1S/C15H16ClN3O3S2/c1-8(20)9-6-24-14(19-9)10-7-23-13(18-10)5-17-12(22)4-11(21)15(16)2-3-15/h7,9H,2-6H2,1H3,(H,17,22)/t9-/m0/s1
InChIKeyHPHSYNXCOKIALU-VIFPVBQESA-N
XLogP1.94
TPSA88.49 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500385.90
LogP ≤ 51.94
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide?
The IUPAC name of N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide (CID 157050337) is N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide.
What is the SMILES notation for N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide?
The canonical SMILES for N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide is CC(=O)[C@@H]1CSC(c2csc(CNC(=O)CC(=O)C3(Cl)CC3)n2)=N1.
What is the InChIKey of N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide?
The InChIKey is HPHSYNXCOKIALU-VIFPVBQESA-N. The full InChI is InChI=1S/C15H16ClN3O3S2/c1-8(20)9-6-24-14(19-9)10-7-23-13(18-10)5-17-12(22)4-11(21)15(16)2-3-15/h7,9H,2-6H2,1H3,(H,17,22)/t9-/m0/s1.
What are the key properties of N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide?
N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide has a molecular weight of 385.90 g/mol, XLogP of 1.94, 7 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[(4R)-4-acetyl-4,5-dihydro-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]methyl]-3-(1-chlorocyclopropyl)-3-oxopropanamide is sourced from PubChem (CID 157050337), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).